Poor-quality medicines: from knowledge to control and prevention

Comment

Raffaella M Ravinetto. Pathog Glob Health. 2014 Jun.

. 2014 Jun;108(4):171-2.

doi: 10.1179/2047772414Z.000000000207.

No abstract available

Comment on

Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.
Tabernero P, Fernández FM, Green M, Guerin PJ, Newton PN. Tabernero P, et al. Malar J. 2014 Apr 8;13:139. doi: 10.1186/1475-2875-13-139. Malar J. 2014. PMID: 24712972 Free PMC article.

1. Caudron J-M, Ford N, Henkens M, Mace C, Kiddle-Monroe R, Pinel J. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Tropical Medicine and International Health. 2008;13:1062–72. - PubMed
1. Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health. Considerations in defining poor quality medicines. PLoS Med. 2011;8(12):e1001139. doi:10.1371/journal.pmed.1001139. - PMC - PubMed
1. Tabernero P, Fernandez FM, Green M, Guerin P, Newton PN. Mind the gaps – the epidemiology of poor-quality anti-malarials in the malarious word – analysis of the WorldWide Antimalarial Resistance Network database. Mal J. 2014;13:19. - PMC - PubMed
1. Gillet P, Maltha J, Hermans V, Ravinetto R, Bruggeman C, Jacobs J. Malaria rapid diagnostic kits: quality of packaging, design and labeling of boxes and components and readability and accuracy of information inserts. Mal J. 2011;10(39) doi:10.1186/1475–2875–10–39. - PMC - PubMed
1. Bonati M. Drug therapy. Once again, children are the main victims of fake drugs. Arch Dis Child. 2009;94:468. - PubMed